FDA Clears Respiratory Panel That Can Detect More Than 20 Pathogens
The panel is the first offering in a deep and broad pipeline of assays planned for QIAstat-Dx in the United States.
Read MorePosted by Chaunie Brusie | Jul 9, 2019 | Gastrointestinal Infections, Respiratory Disease, Swabs |
The panel is the first offering in a deep and broad pipeline of assays planned for QIAstat-Dx in the United States.
Read MorePosted by Chaunie Brusie | Jul 8, 2019 | Molecular Diagnostics |
Inclusion of VZV along with HSV-1 and HSV-2 testing may enable clinicians to provide improved therapeutic decisions and advice.
Read MorePosted by Chaunie Brusie | Jun 30, 2019 | Research |
Infection with a previously unknown strain of the bacterium Leptospira interrogans triggered unusual neurological symptoms suggestive of myasthenia gravis.
Read MorePosted by Chaunie Brusie | Jun 30, 2019 | Point-of-Care |
The visually read tests deliver up to 1,000-fold improvement in sensitivity to support surveillance and elimination efforts against global epidemics.
Read MorePosted by Chaunie Brusie | Jun 10, 2019 | Breast, Microscopy |
The Ventana HER2 dual ISH DNA probe cocktail assay provides clear results to pathology labs more quickly, enabling clinicians to make treatment decisions earlier.
Read More